Home > Healthcare > Biotechnology > Biotechnology R&D > Aptamers Market

Aptamers Market Trends

Report ID: GMI6507
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Aptamers Market Trends

The increasing prevalence of chronic and rare diseases will boost the industry gains. For instance, according to the American Cancer Society report, in 2022, there were an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the U.S. alone. As the burden of these conditions continues to rise, the demand for innovative and targeted therapeutic solutions becomes increasingly urgent. Therefore, aptamers, with versatile nature enables the development of precision therapies tailored to the unique characteristics of each ailment, paving the way for more effective treatment strategies. Also, the flexibility of aptamers in targeting diverse disease markers, enable to opt for precision medicine approaches.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market size for aptamers was USD 2.9 billion in 2023 and will reach USD 15.1 billion by 2032 due to their growing advantages over traditional antibodies.

DNA-based market registered 63.4% revenue share in 2022 and is expected to witness significant growth by 2032 impelled by its escalating demand in versatile and well-established platforms.

North America held 43.6% of the aptamers industry share in 2022 and will witness substantial CAGR through 2032 due to the increasing presence of well-established pharmaceutical and biotechnology industry in the region.

Who are the key players in the aptamers market?